(Q48417417)

11 February 2018

title

Glial fibrillary acidic protein is a major target of glycoxidative and lipoxidative damage in Pick's disease. (English)

1 reference

11 February 2018

author

Reinald Pamplona

8

1 reference

11 February 2018

author name string

G Muntané

1

1 reference

11 February 2018

E Dalfó

2

1 reference

11 February 2018

A Martínez

3

1 reference

11 February 2018

M J Rey

4

1 reference

11 February 2018

J Avila

5

1 reference

11 February 2018

M Pérez

6

1 reference

11 February 2018

M Portero

7

1 reference

11 February 2018

V Ayala

9

1 reference

11 February 2018

I Ferrer

10

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 October 2006

1 reference

11 February 2018

Journal of Neurochemistry

published in

1 reference

11 February 2018

volume

99

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

177-185

1 reference

11 February 2018

The expression of creatine kinase isoenzymes in neocortex of patients with neurodegenerative disorders: Alzheimer's and Pick's disease.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Oxidation of cytosolic proteins and expression of creatine kinase BB in frontal lobe in different neurodegenerative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Early changes in glial reactivity and lipid peroxidation in diabetic rat retina: effects of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Oxidatively modified proteins in aging and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Astrocytic degeneration relates to the severity of disease in frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Evidence for oxidative stress in Pick disease and corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Oxidative modifications and aggregation of Cu,Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Evidence of oxidative stress in the neocortex in incidental Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Increase of glial fibrillary acidic protein fragments in the spinal cord of motor neuron degeneration mutant mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Increased expression of glial fibrillary acidic protein fragments and mu-calpain activation within the hippocampus of prion-infected mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

The p38 pathway is activated in Pick disease and progressive supranuclear palsy: a mechanistic link between mitogenic pathways, oxidative stress, and tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Clinicopathological correlates in frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Glial fibrillary acidic protein is greatly modified by oxidative stress in aceruloplasminemia brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Identification of advanced glycation end products of the Maillard reaction in Pick's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Structural analysis of Pick's disease-derived and in vitro-assembled tau filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Proteomic analysis of glial fibrillary acidic protein in Alzheimer's disease and aging brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Distribution of brain atrophy in behavioral variant frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation. Effects of Alzheimer disease and identification of lipoxidation targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Active stress kinase p38 enhances and perpetuates abnormal tau phosphorylation and deposition in Pick's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

4-hydroxynonenal and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Sporadic Pick's disease: a tauopathy characterized by a spectrum of pathological tau isoforms in gray and white matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2006.04032.X

10.1111/J.1471-4159.2006.04032.X

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

16987245

1 reference

11 February 2018